Inovio Pharmaceuticals Inc (INO): Eigentümerstruktur
Der letzte verfügbare Schlusskurs ist 30.07.2026. Die angezeigten Informationen beziehen sich auf den historischen Stand und sind nicht tagesaktuell.
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 3,433 US Dollar | 2 | 1 | 2 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 82.273.237 | 20,21 | 9,76 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Inovio Pharmaceuticals Inc
Mitarbeiter 112
Handelsplatz NASDAQ
Ticker Symbol INO
IPO Datum 1998-02-12
Adresse 660 West Germantown Pike, Plymouth Meeting, PA, United States, 19462
Webseite https://www.inovio.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Dr. Jacqueline E. Shea Ph.D. | CEO, President & Director |
| 2 | Mr. Peter D. Kies | Chief Financial Officer |
| 3 | Dr. Michael Sumner B.S., M.B.A., M.D. | Chief Medical Officer & Head of Development |
| 4 | Dr. Laurent M. Humeau Ph.D. | Chief Scientific Officer & Chairman of the Scientific Advisory Board |
| 5 | Mr. Robert L. Crotty J.D. | General Counsel, Corporate Secretary & Chief Compliance Officer |
| 6 | Ms. Jennie Willson | Director of Communications |
| 7 | Mr. E. J. Brandreth MBA | Senior Vice President of Quality Assurance |
| 8 | Dr. Jeffrey Skolnik M.D. | Senior Vice President of Clinical Development |
| 9 | Mr. Robert J. Juba Jr. | Senior Vice President of Biological Manufacturing & Clinical Supply Management |
| 10 | Mr. Shawn D. Bridy M.A., M.B.A. | Senior Vice President of Business Development |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | FMR Inc | 11,35% | 9,01 Mio. USD |
| 2 | Vanguard Group Inc | 4,03% | 3,20 Mio. USD |
| 3 | HHG PLC | 4,02% | 3,19 Mio. USD |
| 4 | Vanguard Capital Management, LLC | 3,53% | 2,80 Mio. USD |
| 5 | Boxer Capital Management, LLC | 2,88% | 2,29 Mio. USD |
| 6 | D. E. Shaw & Co LP | 2,69% | 2,14 Mio. USD |
| 7 | ADAR1 Capital Management LLC | 1,79% | 1,42 Mio. USD |
| 8 | Millennium Management LLC | 1,71% | 1,36 Mio. USD |
| 9 | Eversept Partners, LP | 1,26% | 1,00 Mio. USD |
| 10 | Adage Capital Partners Gp LLC | 0,98% | 0,78 Mio. USD |
| 11 | Geode Capital Management, LLC | 0,97% | 0,77 Mio. USD |
| 12 | BlackRock Inc | 0,80% | 0,64 Mio. USD |
| 13 | Renaissance Technologies Corp | 0,78% | 0,62 Mio. USD |
| 14 | Diadema Partners LP | 0,68% | 0,54 Mio. USD |
| 15 | Vanguard Fiduciary Trust Co | 0,48% | 0,38 Mio. USD |
| 16 | Two Sigma Investments LLC | 0,47% | 0,38 Mio. USD |
| 17 | Northern Trust Corp | 0,36% | 0,29 Mio. USD |
| 18 | State Street Corp | 0,36% | 0,29 Mio. USD |
| 19 | Citadel Advisors Llc | 0,35% | 0,28 Mio. USD |
| 20 | GSA Capital Partners LLP | 0,32% | 0,26 Mio. USD |